Boundless Bio (BOLD) Price Target Increased by 33.33% to 4.08
The average one-year price target for Boundless Bio (NasdaqGS:BOLD) has been revised to $4.08 / share. This is an increase of 33.33% from the prior estimate of $3.06 dated February 21, 2026.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $4.04 to a high of $4.20 / share. The average price target represents an increase of 267.57% from the latest reported closing price of $1.11 / share.
What is the Fund Sentiment?
There are 42 funds or institutions reporting positions in Boundless Bio. This is an decrease of 21 owner(s) or 33.33% in the last quarter. Average portfolio weight of all funds dedicated to BOLD is 0.03%, an increase of 63.68%. Total shares owned by institutions decreased in the last three months by 9.30% to 9,025K shares.
What are Other Shareholders Doing?
Citadel Advisors holds 1,354K shares representing 6.04% ownership of the company. In its prior filing, the firm reported owning 876K shares , representing an increase of 35.27%. The firm increased its portfolio allocation in BOLD by 31.89% over the last quarter.
Stonepine Capital Management holds 710K shares representing 3.17% ownership of the company. In its prior filing, the firm reported owning 413K shares , representing an increase of 41.77%. The firm increased its portfolio allocation in BOLD by 50.47% over the last quarter.
Sectoral Asset Management holds 679K shares representing 3.03% ownership of the company. No change in the last quarter.
Wellington Management Group Llp holds 556K shares representing 2.48% ownership of the company. No change in the last quarter.
Renaissance Technologies holds 341K shares representing 1.52% ownership of the company. In its prior filing, the firm reported owning 224K shares , representing an increase of 34.52%.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.